FDA
-
-
-
-
-
-
-
FDA rejects Lantheus drug application over manufacturing issues
-
-
-
-
-
-
-
FDA extends review of Lantheus' LNTH-2501 imaging drug by three months
-
-
-
-
-
-
-
Lantheus Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
-
-
-
-
-
-
-
FDA accepts Lantheus application for Alzheimer's tau imaging agent
-
-
-
-
-
-
-
Lantheus Announces FDA Acceptance of NDA for New Formulation for Market-Leading PSMA PET Imaging Agent
-
-
-
-
-
-
-
Lantheus Holdings (LNTH) Announces Sale of SPECT Business to SHINE Technologies
-
-
-
-
-
-
-
Lantheus Holdings (LNTH) to Acquire Evergreen Theragnostics for Upfront Payment of $250M
-
328,512 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

